Breaking News
-
MPO's Most Read Stories This Week—June 25
A listing of the most popular items from the past seven days.Michael Barbella, Managing Editor 06.25.22
-
Patient Monitoring
Magnetic Insight Announces $17 Million in Series B Funding
Plans to expand magnetic particle imaging and monitoring technology into clinical applications.Charles Sternberg, Associate Editor 06.24.22
-
BreatheSuite Adds Brad Fluegel to its Board
Fluegel was most recently senior VP and chief healthcare commercial market development officer for Walgreen Co.Michael Barbella, Managing Editor 06.24.22
-
Diagnostics
Labcorp Launches At-Home Collection Device for Diabetes Risk Testing
The test uses a dried blood technology to give a snapshot of the body’s average blood sugar levels over time.Michael Barbella, Managing Editor 06.24.22
-
Digital Health
Thirona, Free Flow Medical Partner on COPD Solutions
Thirona’s LungQ software will provide quantifications of anatomical volumes and disease distribution to power Free Flow Medical's Compass service.Michael Barbella, Managing Editor 06.24.22
-
Smart Sleep Tracking Products Market to Sustain Double-Digit Growth
Need to improve sleep is expected to drive the global market through 2028.Michael Barbella, Managing Editor 06.24.22
-
BBS Automation Acquires Kahle Automation
Accelerates its MedTech/Life Sciences strategy.Charles Sternberg, Associate Editor 06.23.22
-
Diagnostics
Thermo Fisher Scientific, Bio-Techne Develop Kidney Rejection Test
Test will allow organ transplant teams to detect potential kidney rejection at a much earlier point, based on exosome mRNA markers.Michael Barbella, Managing Editor 06.23.22
-
Robust Growth Seen for Vision Impairment Devices Market
Increasing prevalence of visual impairment, blindness, and eye disorders are expected to drive the worldwide sector.Michael Barbella, Managing Editor 06.23.22
-
Diagnostics
Global IVD Market to Top $135B in the Next Decade
Growth is contingent on the increasing prevalence of chronic and infectious diseases.Michael Barbella, Managing Editor 06.23.22
-
BD Recalls Certain Intraosseous Products
Affected lots include needle set kits, manual driver kits, and powered drivers.Sam Brusco, Associate Editor 06.23.22
-
Thirona, Pulmonx Extend Strategic Partnership
Collaboration has enabled Pulmonx to provide customers with StratX CT scan analysis.Michael Barbella, Managing Editor 06.23.22
-
Diagnostics
Intermountain Healthcare & Siemens Healthineers Open 3 Tellica Outpatient Imaging Centers
Siemens Healthineers provides medical imaging equipment & related services to Tellica for these & future outpatient imaging centers.Charles Sternberg, Associate Editor 06.23.22
-
Cardiovascular
Cardiologs Shares Study Demonstrating the Capability of AI in Predicting Atrial Fibrillation
Cardiolog’s network outperformed ECG features previously shown to be predictive of AFib.Charles Sternberg, Associate Editor 06.22.22
-
NHS England Selects Spectra Optia Apheresis System to Treat Sickle Cell Disease
Adoption of Terumo Blood and Cell Technologies’ Spectra Optia will save the UK’s NHS an expected $16 million per year.Charles Sternberg, Associate Editor 06.22.22
-
Software & IT
Vamstar Closes $9.5M Series A to Expand AI-Based Healthcare Supply Chain Platform
Vamstar is a medical supply and pharmaceutical global sourcing and procurement platform.Sam Brusco, Associate Editor 06.22.22
-
Cardiovascular
BioSig Begins New Evaluation Agreement with Cleveland Clinic
Cleveland Clinic will evaluate the PURE EP system for 60 days.Sam Brusco, Associate Editor 06.22.22
-
Neurological
Carthera's SonoCloud Ultrasound Device Gains Breakthrough Status
SonoCloud disrupts the blood-brain barrier to allow entry of more therapeutic compounds into the brain.Sam Brusco, Associate Editor 06.22.22
-
Cardiovascular
Vektor Medical Promotes Rob Krummen to CEO
He was previously the non-invasive cardiac arrhythmia mapping company's president and COO.Sam Brusco, Associate Editor 06.22.22
-
AcuityMD Raises $31 Million in Series A Funding
Company plans to use the money to expand its engineering team over the next year.Michael Barbella, Managing Editor 06.22.22
